<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9504688</journal-id><journal-id journal-id-type="pubmed-jr-id">8741</journal-id><journal-id journal-id-type="nlm-ta">J Occup Environ Med</journal-id><journal-id journal-id-type="iso-abbrev">J. Occup. Environ. Med.</journal-id><journal-title-group><journal-title>Journal of occupational and environmental medicine</journal-title></journal-title-group><issn pub-type="ppub">1076-2752</issn><issn pub-type="epub">1536-5948</issn></journal-meta><article-meta><article-id pub-id-type="pmid">29200190</article-id><article-id pub-id-type="pmc">5805586</article-id><article-id pub-id-type="doi">10.1097/JOM.0000000000001178</article-id><article-id pub-id-type="manuscript">HHSPA907538</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Libby Amphibole Disease: Pulmonary Function and CT Abnormalities in Vermiculite Miners</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Miller</surname><given-names>Albert</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Szeinuk</surname><given-names>Jaime</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Noonan</surname><given-names>Curtis W.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name><surname>Henschke</surname><given-names>Claudia I.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Pfau</surname><given-names>Jean</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Black</surname><given-names>Brad</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A5">e</xref></contrib><contrib contrib-type="author"><name><surname>Yankelevitz</surname><given-names>David F.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Mingzhu</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ying</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Yip</surname><given-names>Rowena</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>McNew</surname><given-names>Tracy</given-names></name><degrees>MPA</degrees><xref ref-type="aff" rid="A5">e</xref></contrib><contrib contrib-type="author"><name><surname>Linker</surname><given-names>Laura</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Flores</surname><given-names>Raja</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">a</xref></contrib></contrib-group><aff id="A1">
<label>a</label>Mount Sinai Health System, Icahn School of Medicine, New York, NY</aff><aff id="A2">
<label>b</label>Northwell Health, Department of Occupational Medicine, Epidemiology and Prevention, Great Neck, NY</aff><aff id="A3">
<label>c</label>University of Montana, Missoula, MT</aff><aff id="A4">
<label>d</label>Montana State University, Bozeman, MT</aff><aff id="A5">
<label>e</label>Center for Asbestos Related Disease, Libby, MT</aff><author-notes><corresp id="FN1">Corresponding Author: Raja M. Flores, MD, Ames Professor of Cardiothoracic Surgery, Chairman, Department of Thoracic Surgery, Mount Sinai Health System, Icahn School of Medicine, One Gustave L. Levy Place, Box 1023, New York, NY 10029, Telephone: 212-241-9466, Fax: 212-659-1521, <email>raja.flores@mountsinai.org</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>22</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>2</month><year>2019</year></pub-date><volume>60</volume><issue>2</issue><fpage>167</fpage><lpage>173</lpage><!--elocation-id from pubmed: 10.1097/JOM.0000000000001178--><abstract><sec id="S1"><title>Objective</title><p id="P1">This article describes radiologic and pulmonary function findings among miners exposed to Libby amphibole. Computed tomography permits the detection of the characteristic thin, lamellar pleural thickening (LPT).</p></sec><sec id="S2"><title>Methods</title><p id="P2">Individuals who worked at the mine for a minimum of 6 months had chest CT and pulmonary function tests.</p></sec><sec id="S3"><title>Results</title><p id="P3">Pleural thickening was noted in 223 (87%) of the 256 miners, parenchymal abnormalities in 49 (19%). LPT, found in 151 (68%), was associated with low values of forced vital capacity and diffusion capacity and significantly lower values in all pulmonary function tests when associated with parenchymal abnormalities.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">Eighty-seven percent of miners exposed to Libby Amphibole had pleural abnormalities on CT. LPT alone, and more so with parenchymal abnormalities, resulted in decreased pulmonary function. The importance of this easily-missed LPT is demonstrated by its high frequency and significant functional effects.</p></sec></abstract><kwd-group><kwd>Libby Amphibole</kwd><kwd>Asbestos</kwd><kwd>Pleural Disease</kwd><kwd>Vermiculite Miners</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S5"><title>INTRODUCTION</title><p id="P5">High rates of chest radiologic abnormalities have been reported in the population in and around Libby, MT, due to exposure to amphibole asbestos that contaminated the Libby vermiculite mine outside the town<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. Morbidity and mortality from Libby Amphibole (LA) asbestos-related disease has been reported<sup><xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref></sup>. Sullivan reported that standardized mortality ratios for lung cancer, cancer of the pleura and asbestosis were 1.7, 23.3 and 165.8, respectively, when compared to the US white male population of the same age category<sup><xref rid="R6" ref-type="bibr">6</xref></sup>. Similar amphiboles have been detected in surface deposits in Nevada and Arizona<sup><xref rid="R8" ref-type="bibr">8</xref></sup>. A recent publication provided evidence that the increased incidence of mesothelioma in women and young individuals in southern Nevada may be linked to such environmental amphibole exposure<sup><xref rid="R9" ref-type="bibr">9</xref></sup>. In the Libby vermiculite-exposed population, we observed a different type of pleural disease in addition to the well-described circumscribed or diffuse pleural thickening, which are typically found in asbestos-exposed individuals. We called this different type of pleural disease &#x0201c;lamellar pleural thickening&#x0201d; (LPT)<sup><xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R10" ref-type="bibr">10</xref></sup>.</p><p id="P6">We previously reported illustrative cases of patients who developed pulmonary disease after LA-exposure<sup><xref rid="R10" ref-type="bibr">10</xref></sup>. These patients presented rapidly progressing dyspnea, chest pain, worsening pleural radiological changes, a restrictive pattern in pulmonary function tests and rapid loss of pulmonary function. These findings are atypical when compared to classical asbestos-related disease. In a group of 189 volunteers who resided in Libby as children and adolescents but left before adulthood, 96 (48%) had pleural thickening on CT imaging with almost half of these being LPT. The severity of this LPT correlated with a decrease in pulmonary function<sup><xref rid="R7" ref-type="bibr">7</xref></sup>. LPT as found in Libby may be seen elsewhere but missed due to its non-traditional radiological features. In this report, we describe the radiologic and pulmonary function findings in former Libby miners who have been evaluated on repeated visits at the Center for Asbestos Related Disease (CARD) in Libby, MT, and who constitute the most heavily exposed group of the Libby population.</p></sec><sec sec-type="methods" id="S6"><title>METHODS</title><p id="P7">During its 65 years of operation from the 1920s to 1990, 1862 individuals worked at the Libby vermiculite mine<sup><xref rid="R11" ref-type="bibr">11</xref></sup>. In July 2000, the CARD was established and has provided ongoing follow-up and imaging for the Libby exposed community. The CARD roster consists of approximately 5500 people; about 2000 of whom have been diagnosed with asbestos related disease (Black B, personal communication). This population includes former workers at the mine who have been evaluated on repeated clinical visits with extensive information on their LA exposure, medical history, full pulmonary function tests (PFTs), and CT imaging.</p><sec id="S7"><title>Inclusion criteria</title><p id="P8">This report focuses on the 256 subjects who met the following entry criteria: a self-reported minimum six month history of working directly or as a contractor for the mine company, and had CT imaging at the time of inclusion. A total of 477 CARD patients initially identified themselves as miners. Seventy-two were removed as their work experience was less than six months, and an additional 18 were removed as they worked as contractors after the mine closed. Eighty-four of the remaining miners did not consent to participate, and 47 did not have CT imaging available at the time of inclusion. <xref ref-type="fig" rid="F1">Figure 1</xref> depicts the cohort. The research was performed under approval of the Institutional Review Board Spokane, WA.</p><p id="P9">All 256 subjects had completed standardized exposure questionnaires, including occupational, residential<sup><xref rid="R12" ref-type="bibr">12</xref></sup> and smoking histories, and physical examination prior to inclusion. Exposure histories were analyzed as described previously<sup><xref rid="R12" ref-type="bibr">12</xref></sup>, and PFTs were performed at the CARD using American Thoracic Society criteria<sup><xref rid="R13" ref-type="bibr">13</xref></sup>. Static lung volumes were measured via plethysmography. Reference values for spirometry were from Hankinson<sup><xref rid="R14" ref-type="bibr">14</xref></sup>, lung volumes were from Crapo<sup><xref rid="R15" ref-type="bibr">15</xref></sup> and DLco were from Miller<sup><xref rid="R16" ref-type="bibr">16</xref></sup>. Lower Limits of Normal (LLN), or upper limits of normal for residual volume, were used as criteria of abnormality.</p></sec><sec id="S8"><title>CT imaging</title><p id="P10">Beginning in 2001, CT imaging was added to the radiologic testing performed at the CARD and it has provided a significant improvement in the detection of the pleural thickening frequently observed in the population<sup><xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R17" ref-type="bibr">17</xref></sup>. Standard-dose chest CT scans were performed at the local hospital utilizing a 16 slice CT GE LightSpeed scanner (at 120 kVp and no more than 441 mAs) with 1-mm collimation. All identifiers were removed from the CT scan files, and readers were blind as to history and exposure status.</p><p id="P11">The most recent CT scan prior to date of inclusion was interpreted by consensus by academic thoracic radiologists with experience evaluating Libby disease (ML, YL, CH, DY), using lung (&#x02212;500 level, 1400 width), mediastinal (40 level, 400 width), and extended-mediastinal windows (&#x02212;200 level, 3500 width, with adjustments)<sup><xref rid="R7" ref-type="bibr">7</xref></sup>. Radiologists performed standard clinical interpretation and the International Classification of Occupational and Environmental Respiratory Disease scoring system (ICO-ERD)<sup><xref rid="R18" ref-type="bibr">18</xref></sup> as a CT-equivalent of the International Labour Organization Classification of x-rays for Pneumoconiosis<sup><xref rid="R19" ref-type="bibr">19</xref></sup>. In addition, radiologists were asked to differentiate between LPT<sup><xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R10" ref-type="bibr">10</xref></sup> and circumscribed pleural thickening (CPT). When both were identified on CT scans, radiologists further determined if the pleural thickening was predominantly CPT or predominantly LPT.</p><p id="P12">CPT is defined as areas of pleural thickening with well-demarcated edges<sup><xref rid="R20" ref-type="bibr">20</xref></sup>. Diffuse pleural thickening on CT scan has been defined as a continuous sheet of pleural thickening more than 5 cm wide, more than 8 cm in cranio-caudal extent and more than 3 mm thick<sup><xref rid="R21" ref-type="bibr">21</xref></sup>. The 2000 International Labour Organization Classification of Radiographs of Pneumoconiosis defines diffuse pleural thickening as that &#x0201c;extending up the lateral chest wall &#x02026; only in the presence of, and in continuity with, an obliterated costophrenic angle&#x0201d;<sup><xref rid="R19" ref-type="bibr">19</xref></sup>. These types of pleural thickening are different from what we have termed as LPT (<xref ref-type="fig" rid="F2">Figure 2</xref>). We describe LPT as a thin layer of pleural thickening seen on CT scans internal and parallel to the ribs, but distinguished from subpleural fat<sup><xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R22" ref-type="bibr">22</xref></sup>. It progressively extends vertically and along the inner border of the chest wall<sup><xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R10" ref-type="bibr">10</xref></sup>. It may progress in thickness and may calcify, becoming easier to identify and confirming its earlier recognition<sup><xref rid="R10" ref-type="bibr">10</xref></sup>.</p></sec><sec id="S9"><title>Statistical Analysis</title><p id="P13">We calculated summary statistics of demographics, exposure estimates, and CT and PFT findings. Comparison between independent variables and categories of CT findings (i.e., CT groups) were evaluated by chi-square and analysis of variance. PFT percent predicted values, or ratio for FEV<sub>1</sub>/FVC, were compared between CT groups in general linear models, adjusting for covariates. Associations between abnormal PFT findings (i.e., below LLN) and CT findings were evaluated with unconditional logistic regression models. Initially, we modeled associations separately for each CT finding adjusted for covariates of latency and history of smoking. To account for multiple CT findings within miners we further included all CT findings in the model. All data analyses were conducted using SAS v9.3 (Cary, NC).</p></sec></sec><sec sec-type="results" id="S10"><title>RESULTS</title><p id="P14"><xref ref-type="table" rid="T1">Table 1</xref> provides the descriptive data for the 256 miners: 243 (95%) were male and almost half were 65 years or older (115, 45%). Twenty seven percent lived in Lincoln County for 25 years or more prior to the closing of the mine, and the mean (standard deviation (SD)) occupational latency (i.e., years elapsed between first year of mine work and year of the CT used for the study) was 39 (8.2) years. Mean (SD) body mass index (BMI) was 31 (6.9) kg/m<sup>2</sup>, and over half (52.5%) of the participants were obese (i.e., BMI &#x02265; 30). Among the 256 miners, 89 (34.8%) were never smokers, 43 (16.8%) were current smokers, 123 (48.1%) were former smokers, and 1 refused to provide the information. Sufficient information to calculate the pack-years of smoking was available on 146 (88%) of the 166 smokers and the mean (SD) was 30 (26). Mean (SD) quit time for the 123 former smokers was 26 years (14).</p><p id="P15"><xref ref-type="table" rid="T2">Table 2</xref> shows the results of the CT interpretation for the 256 miners. No abnormalities could be identified on the CT scan in 30 (11.7%) of the miners, while 226 (88.3%) had some abnormality. Pleural thickening was the most frequent abnormality, noted in a total of 223 (87.1%). Among these 223 miners, 151 (67.7%) had only or predominantly LPT, and 72 (32.3%) had only or predominantly CPT. The 49 miners (19%) in whom parenchymal abnormalities were identified are reported in <xref ref-type="table" rid="T2">Table 2</xref> using the ICO-ERD classification. These parenchymal abnormalities identified correspond to those seen in asbestosis (irregular opacities). Forty-seven of these had concomitant pleural thickening: 37 had LPT and the remaining 10 had CPT. Using clinical interpretation of the chest CT scan, two-thirds (33) of these 49 miners were also read as positive for &#x0201c;interstitial lung disease&#x0201d;. Emphysema with no other parenchymal abnormalities was found in 57 (22.3%) miners, all but one had pleural thickening (56/57). Fifteen of the 256 miners (5.9%) had emphysema, pleural thickening and irregular opacities.</p><p id="P16">For subsequent comparisons with PFT findings, we grouped participants into eight mutually exclusive CT categories given in <xref ref-type="table" rid="T3">Table 3</xref>: CT negative (n = 30), CPT only (n = 35), LPT only (n = 52), both types but predominantly CPT (n = 11), both types but predominantly LPT (n = 37), CPT plus irregular opacities (n = 5), LPT plus irregular opacities (n = 27) and emphysema (n = 57). The two miners who had irregular opacities but no pleural thickening or emphysema were not included in these further analyses.</p><p id="P17">The participants&#x02019; characteristics with respect to the above described eight mutually exclusive CT categories are given in <xref ref-type="table" rid="T3">Table 3</xref>. Miners with any type of pleural thickening were of similar age as those with no abnormalities on CT scan, while those miners who had parenchymal abnormalities were significantly older. The few females in the study were more likely to be in the CT-negative group. Mean BMI was similar across eight groups, except it was significantly lower for those with emphysema (p &#x0003c; 0.05). Smoking history was similar among the eight groups, except for the emphysema group which was significantly higher (P&#x0003c; 0.01). Years of working at the mine company, years of residence and total environmental exposure were not significantly different between the CT positive and the CT negative groups, except those with emphysema who had longer residency time in the Libby area.</p><p id="P18">PFT data were available for 241 (94%) of miners. To best describe pulmonary function relevant to imaging studies, we limited our analysis to those miners whose PFTs were done within one year of the date of CT. Fourteen records were removed by this exclusion, resulting in 227 records with FEV<sub>1</sub> and FVC data. Miners who were excluded from further PFT analysis (n=14) were not different from those included (n=227) with respect to percent male (93% versus 95%, respectively), percent overweight or obese (91% versus 88%, respectively) or percent current or former smokers (64% versus 65%, respectively). Fewer measures were available for DLco (n=158) and lung volumes (n=135). Mean PFT values by CT group are shown in <xref ref-type="table" rid="T4">Table 4</xref> and all comparisons were adjusted for latency-years and smoking history. Those with both pleural thickening types were classified according to the predominant finding as identified by the radiologists, i.e., CPT or LPT. All the PFTs in the group with both LPT and parenchymal abnormalities were significantly lower than the CT negative group (p&#x0003c;0.05). DLco was lowest in the group with LPT and parenchymal abnormalities (p&#x0003c;0.002 compared to CT negative) and was lower in those with LPT than in those with CPT (p=0.016). The 57 miners with emphysema had lower values for FEV<sub>1</sub>, FEV<sub>1</sub>/FVC ratio and DLco compared to the CT negative (<xref ref-type="table" rid="T4">Table 4</xref>).</p><p id="P19"><xref ref-type="table" rid="T5">Table 5</xref> shows the association between frequency of abnormal PFTs and CT findings. A substantial proportion of miners had FEV<sub>1</sub> (35%), FVC (32%) and DLco (25%) below LLN. Adjusting only for latency and smoking history, we showed significantly elevated risk estimates for abnormal FEV<sub>1</sub> and FVC among those with LPT compared to no pleural findings. Risk estimates for these parameters among those with CPT were not different from those with no pleural thickening. When further adjusting for other CT findings, the odds ratio for abnormal FVC remained independently elevated among those with LPT compared to no pleural thickening (OR (95% CI) = 3.9 (1.1 &#x02013; 14)). Presence of irregular opacities and presence of emphysema were consistently associated with frequency of abnormal PFTs. Additional modeling using years of work as a proxy for exposure did not appreciably change (&#x0003c; 5%) the risk estimates (data not shown). Because we had insufficient data to calculate pack-years for a substantial portion of the observations (i.e., approximately 12% of the smokers with PFT data), we used a categorical variable for smoking history in our primary analysis. In sensitivity analyses, we used pack-years in place of the categorical variable; the effect estimates for CT findings and PFT abnormality were similar, but that had larger 95% confidence intervals. For example, OR (95% CI) for CPT and abnormal FVC was 3.6 (1.0 &#x02013; 13).</p><p id="P20">LPT which cannot be identified on chest radiographs and is even difficult to recognize on CT scans until it has advanced or calcified, does lead to a decreased FEV<sub>1</sub>, FVC, TLC and DLco as shown in <xref ref-type="table" rid="T4">Tables 4</xref> and <xref ref-type="table" rid="T5">5</xref>.</p></sec><sec sec-type="discussion" id="S11"><title>DISCUSSION</title><p id="P21">This report focuses on a population of individuals who were heavily exposed to LA as a result of their occupation at the mine. Prior reports using chest radiographs rather than CT scans have demonstrated that Libby miners had pleural thickening, parenchymal abnormalities and restrictive findings on spirometry<sup><xref rid="R23" ref-type="bibr">23</xref></sup>.</p><p id="P22">Our investigation expands on previous studies by using the more sensitive and more accurate imaging modality of CT and the full spectrum of PFTs to evaluate the effect of pleural thickening and parenchymal abnormalities on pulmonary function findings. We found that 223 (87%) of the 256 miners had pleural thickening and among them, 47 (21%) had associated parenchymal abnormalities. Among the 223 with pleural thickening, 68% had LPT rather than the classical CPT. We have previously introduced the concept of LPT to describe a thin layer of pleural thickening internal and parallel to the ribs, distinguished from subpleural fat, seen on CT scans of LA exposed individuals<sup><xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R10" ref-type="bibr">10</xref></sup>. LPT is different from the traditional diffuse pleural thickening classified under the International Labour Organization (ILO) guidelines for reading x-rays of pneumoconiosis<sup><xref rid="R19" ref-type="bibr">19</xref></sup> and there is no specific category to describe it. While LPT is parietal in location, it does not fit the definition CPT since it lacks well-demarcated edges.</p><p id="P23">LPT cannot be identified on chest radiographs and is even difficult to recognize on CT scans until the pleural thickening becomes advanced or calcified. It does, however, lead to a decreased FEV<sub>1</sub>, FVC, TLC and DLco as shown in <xref ref-type="table" rid="T4">Tables 4</xref> and <xref ref-type="table" rid="T5">5</xref>. Our study demonstrates that occupational exposure to LA leads to high frequencies of pleural thickening, of which the majority of cases are LPT. Lung function deficits are more frequently associated with LPT than with CPT, particularly in the presence of concurrent parenchymal abnormalities. The importance of pleural thickening from LA was demonstrated by our previous study of 198 subjects who had less intense environmental exposure only during childhood and adolescence, 96 (48%) of whom had pleural thickening. Of those with any pleural thickening, LPT was found in 47 (49%)<sup><xref rid="R7" ref-type="bibr">7</xref></sup>.</p><p id="P24">Two recent papers have reported pulmonary function abnormalities associated with CT evaluation of LA exposure. Clark<sup><xref rid="R24" ref-type="bibr">24</xref></sup> found that 90% of 166 Libby vermiculite miners whose medical records between January 2000 and August 2012 were reviewed, presented pleural plaques, the majority of which were described as &#x0201c;bilateral and calcified&#x0201d;. Sixteen percent of these workers had associated pulmonary fibrosis. No differences in PFT results were noted between those with only pleural plaques and those with no abnormalities on CT. Miners with both interstitial and pleural abnormalities had a significantly decreased TLC as compared to those with negative CT scans. Age, smoking and BMI were found to contribute to abnormal pulmonary function. While Clark did not differentiate CPT from LPT, we found similar percentages of overall pleural thickening in our group of miners (90% in Clark&#x02019;s study as compared to 87% in our study). Additionally, similar to Clark&#x02019;s findings, miners with both pleural thickening and parenchymal abnormalities in our study had significantly decreased PFTs. Our study, however, showed that presence of LPT among miners was independently associated with abnormal FVC after adjusting for presence of parenchymal abnormalities, thus showing that LPT alone contributes to impairment of pulmonary function.</p><p id="P25">Lockey and co-workers described CT findings in 191 workers with low exposure to LA working for a vermiculite expansion plant<sup><xref rid="R25" ref-type="bibr">25</xref></sup>. These authors found CT abnormalities in 55% of the workers: 53% had pleural thickening and 13% had parenchymal abnormalities. Localized pleural thickening, the description of which was that of plaques, was far more common and resulted in decreased FVC and FEV<sub>1</sub>. Decreased FVC and FEV<sub>1</sub> were more marked in those who had pleural thickening and other abnormalities. Diffuse pleural thickening was described in only 8%, always in combination with localized thickening or parenchymal abnormalities, resulting in greater reduction in FVC. Our study found a higher incidence of pleural thickening among the Libby miners, which would be expected given that these miners had higher exposures. Similar to Lockey&#x02019;s findings, in our study, miners with CPT had decreased pulmonary function as compared to miners with no abnormalities in their chest CT. Again, no distinction was made between CPT and LPT by Lockey&#x02019;s group, and it is likely that many cases of LPT were not recognized. In a correspondence concerning their paper, Lockey reported results of additional PFTs showing that percent predicted TLC was decreased 3.6% and DLco was decreased 4.1% in those with limited pleural thickening only and much further in those with both pleural thickening and other findings<sup><xref rid="R26" ref-type="bibr">26</xref></sup>.</p><p id="P26">Other studies using CT scans of asbestos-exposed workers have shown that CPT (plaques) is associated with decreased spirometry values<sup><xref rid="R27" ref-type="bibr">27</xref></sup> and diffuse thickening is additionally associated with decreased DLco<sup><xref rid="R28" ref-type="bibr">28</xref></sup>. A study of a large number (1584) of heavily exposed workers (long term insulators) using chest radiographs demonstrated that severity of CPT correlated with decreasing FVC and that diffuse thickening was associated with greater decrease in FVC irrespective of severity<sup><xref rid="R29" ref-type="bibr">29</xref></sup>. This distinction between the effects of different types of pleural thickening on pulmonary function is very similar to the differences observed in this current study between CPT and LPT.</p><p id="P27">The importance of CT evidence of pulmonary fibrosis is demonstrated in our study by the far greater decrease in all measures of pulmonary function in those miners with associated CT-detected parenchymal abnormalities. That the difference is most clearly seen with DLco is consistent with the sensitivity of this measurement for parenchymal lung involvement. That DLco is lower in LPT than CPT alone suggests that LPT may be associated with parenchymal inflammation or fibrosis that is not apparent on standard CT-window settings. A study in insulators using incremental exercise testing demonstrated evidence of parenchymal involvement in those with pleural thickening only and no parenchymal abnormalities on chest radiographs<sup><xref rid="R30" ref-type="bibr">30</xref></sup>.</p><p id="P28">Limitations of this study may include sample selection. The authors believe, however, that the sample is representative of the overall LA mining population, as it included all former miners and contractors who are patients of CARD, which is the local reference center for all individuals exposed to LA. In addition, CARD maintains a nation-wide screening program that targets those who now live elsewhere.</p><p id="P29">The asbestos-related benign and malignant consequences of LA are of national significance since vermiculite was shipped (in open rail cars) throughout North America for processing. The consequences of such exposure have been reported from processing sites<sup><xref rid="R25" ref-type="bibr">25</xref>, <xref rid="R31" ref-type="bibr">31</xref>&#x02013;<xref rid="R37" ref-type="bibr">37</xref></sup>. In addition to the Libby product, similar amphiboles have been found in surface sites in several states in sufficient air-concentrations to cause disease. The elevated rates of mesothelioma in women and in young persons in Southern Nevada are consistent with environmental exposure to asbestos<sup><xref rid="R9" ref-type="bibr">9</xref></sup>. Recognition of the unique radiologic presentation of LA pleural disease is therefore critically important to the diagnosis of individual patients and to the public health of communities.</p></sec></body><back><ack id="S12"><p id="P30">This paper is dedicated to the memory of Dr. Stephen M. Levin. His tireless work for the health and welfare of the Libby community shines as a beacon for those of us who have continued his efforts.</p><p id="P31">Special thanks to Erlin Daley for her editorial assistance.</p><p id="P32"><bold>DISCLOSURE OF GRANT FUNDING</bold></p><p id="P33">Grant Sponsor: NIH/ATSDR/CDC; Grant No. TS000099-01 PI Raja Flores</p><p id="P34">Dr. Yankelevitz reports grants from FAMRI, outside the submitted work; and Dr. David Yankelevitz is a named inventor on a number of patents and patent applications relating to the evaluation of diseases of the chest including measurement of nodules. Some of these, which are owned by Cornell Research Foundation (CRF) are non-exclusively licensed to General Electric. As an inventor of these patents, Dr. Yankelevitz is entitled to a share of any compensation which CRF may receive from its commercialization of these patents.</p><p id="P35">Dr. Henschke reports grants from FAMRI outside the submitted work and Dr. Henschke is a named inventor on a number of patents and patent applications relating to the evaluation of pulmonary nodules on CT scans of the chest which are owned by Cornell Research Foundation (CRF). Since April 2009, Dr. Henschke does not accept any financial benefit from these patents including royalties and any other proceeds related to the patents or patent applications owned by CRF. In addition, Dr. Henschke is the President of the Early Diagnosis and Treatment Research Foundation; she receives no compensation for this service.</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p id="P36"><bold>Conflicts of Interest:</bold></p><p id="P37">The remaining authors have no conflicts of interest to disclose.</p></fn><fn id="FN3" fn-type="con"><p id="P38"><bold>Author Contributions:</bold></p><p id="P39">AM, JS, CWN, CIH, and JP significantly contributed to the drafting and writing of the manuscript.</p><p id="P40">BB, TM, LL and RF further contributed to review and edit the final draft. All these authors have critically revised the manuscript for important intellectual content.</p><p id="P41">AM, JS, CWN, CIH, JP, BB, DFY, TM, LL and RF significantly contributed to conception and/or design of the work, acquisition, analysis and interpretation of data.</p><p id="P42">CWN, CIH and RY performed the statistical and epidemiological analyses.</p><p id="P43">CIH, DFY, ML, YL, BB and JS read and reviewed the CT scans.</p><p id="P44">LL is the overall administrator of the Grant.</p><p id="P45">RF is the PI of the Grant.</p></fn></fn-group><glossary id="GL1"><title>Abbreviation List</title><def-list><def-item><term>BMI</term><def><p id="P46">Body mass index</p></def></def-item><def-item><term>CARD</term><def><p id="P47">Center for Asbestos Related Disease</p></def></def-item><def-item><term>CT</term><def><p id="P48">Computed Tomography</p></def></def-item><def-item><term>CPT</term><def><p id="P49">Circumscribed Pleural Thickening</p></def></def-item><def-item><term>DLco</term><def><p id="P50">Carbon monoxide diffusing capacity of the lung</p></def></def-item><def-item><term>FEV1</term><def><p id="P51">Forced Expiratory Volume in 1<sup>st</sup> second</p></def></def-item><def-item><term>FVC</term><def><p id="P52">Forced Vital Capacity</p></def></def-item><def-item><term>ICO-ERD</term><def><p id="P53">International Classification of HRCT for Occupational and Environmental Respiratory Diseases</p></def></def-item><def-item><term>LA</term><def><p id="P54">Libby Amphibole</p></def></def-item><def-item><term>LLN</term><def><p id="P55">Lower Limits of Normal</p></def></def-item><def-item><term>LPT</term><def><p id="P56">Lamellar Pleural Thickening</p></def></def-item><def-item><term>PFT</term><def><p id="P57">Pulmonary Function Test</p></def></def-item><def-item><term>SD</term><def><p id="P58">Standard Deviation</p></def></def-item><def-item><term>TLC</term><def><p id="P59">Total Lung Capacity</p></def></def-item></def-list></glossary><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peipins</surname><given-names>LA</given-names></name><name><surname>Lewin</surname><given-names>M</given-names></name><name><surname>Campolucci</surname><given-names>S</given-names></name><name><surname>Lybarger</surname><given-names>JA</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Middleton</surname><given-names>D</given-names></name><name><surname>Weis</surname><given-names>C</given-names></name><name><surname>Spence</surname><given-names>M</given-names></name><name><surname>Black</surname><given-names>B</given-names></name><name><surname>Kapil</surname><given-names>V</given-names></name></person-group><article-title>Radiologic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA</article-title><source>Environ Health Perspec</source><year>2003</year><volume>111</volume><fpage>1753</fpage><lpage>1759</lpage></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antao</surname><given-names>VC</given-names></name><name><surname>Larson</surname><given-names>TC</given-names></name><name><surname>Horton</surname><given-names>DK</given-names></name></person-group><article-title>Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases</article-title><source>Curr Opin Pulm Med</source><year>2012</year><volume>18</volume><fpage>161</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">22139761</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehouse</surname><given-names>AC</given-names></name></person-group><article-title>Asbestos-related pleural disease due to tremolite associated with progressive loss of lung function: serial observations in 123 miners, family members, and residents of Libby, Montana</article-title><source>Am J Ind Med</source><year>2004</year><volume>46</volume><fpage>219</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">15307120</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehouse</surname><given-names>AC</given-names></name><name><surname>Black</surname><given-names>CB</given-names></name><name><surname>Heppe</surname><given-names>MS</given-names></name><name><surname>Ruskdeschel</surname><given-names>J</given-names></name><name><surname>Levin</surname><given-names>SM</given-names></name></person-group><article-title>Environmental exposure to Libby asbestos and mesotheliomas</article-title><source>Am J Ind Med</source><year>2008</year><volume>51</volume><fpage>877</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">18651576</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>JC</given-names></name><name><surname>McDonald</surname><given-names>AD</given-names></name><name><surname>Sebastien</surname><given-names>P</given-names></name></person-group><article-title>Heath of vermiculite miners exposed to trace amounts of fibrous tremolite</article-title><source>Br J Ind Med</source><year>1988</year><volume>45</volume><fpage>630</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">2846033</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PA</given-names></name></person-group><article-title>Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study</article-title><source>Environ Health Perspect</source><year>2007</year><volume>115</volume><fpage>579</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">17450227</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szeinuk</surname><given-names>J</given-names></name><name><surname>Noonan</surname><given-names>CW</given-names></name><name><surname>Henschke</surname><given-names>CI</given-names></name><name><surname>Pfau</surname><given-names>JC</given-names></name><name><surname>Black</surname><given-names>B</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Yankelevitz</surname><given-names>DF</given-names></name><name><surname>Liang</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yip</surname><given-names>R</given-names></name><name><surname>Linker</surname><given-names>L</given-names></name><name><surname>McNew</surname><given-names>T</given-names></name><name><surname>Flores</surname><given-names>RM</given-names></name></person-group><article-title>Pulmonary abnormalities as a result of exposure to Libby amphibole during childhood and adolescence &#x02013; The Pre-Adult Latency Study (PALS)</article-title><source>Am J Ind Med</source><year>2017</year><volume>60</volume><fpage>20</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">27859510</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buck</surname><given-names>BJ</given-names></name><name><surname>Goossens</surname><given-names>D</given-names></name><name><surname>Metcalf</surname><given-names>RV</given-names></name><name><surname>McLaurin</surname><given-names>B</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Freudenberger</surname><given-names>F</given-names></name></person-group><article-title>Naturally occurring asbestos: potential for human exposures, Southern Nevada, USA</article-title><source>Soil Sci Soc Am J</source><year>2013</year><volume>77</volume><fpage>2192</fpage><lpage>2204</lpage></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname><given-names>F</given-names></name><name><surname>Buck</surname><given-names>BJ</given-names></name><name><surname>Metcalf</surname><given-names>RV</given-names></name><name><surname>McLaurin</surname><given-names>BT</given-names></name><name><surname>Merkler</surname><given-names>DJ</given-names></name><name><surname>Carbone</surname><given-names>M</given-names></name></person-group><article-title>The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women form southern Nevada</article-title><source>J Thorac Oncol</source><year>2015</year><volume>10</volume><fpage>731</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">25668121</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>B</given-names></name><name><surname>Szeinuk</surname><given-names>J</given-names></name><name><surname>Whitehouse</surname><given-names>AC</given-names></name><name><surname>Levin</surname><given-names>SM</given-names></name><name><surname>Henschke</surname><given-names>CI</given-names></name><name><surname>Yankelevitz</surname><given-names>DF</given-names></name><name><surname>Flores</surname><given-names>RM</given-names></name></person-group><article-title>Rapid progression of pleural disease due to exposure to Libby amphibole:"Not your grandfather&#x02019;s asbestos related disease&#x0201d;</article-title><source>Am I Ind Med</source><year>2014</year><volume>57</volume><fpage>1197</fpage><lpage>1206</lpage></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>TC</given-names></name><name><surname>Antao</surname><given-names>VC</given-names></name><name><surname>Bove</surname><given-names>FJ</given-names></name></person-group><article-title>Vermiculite worker mortality: estimated effects of occupational exposure to Libby amphibole</article-title><source>J Occup Environ Med</source><year>2010</year><volume>52</volume><fpage>555</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">20431408</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noonan</surname><given-names>CW</given-names></name><name><surname>Conway</surname><given-names>K</given-names></name><name><surname>Landguth</surname><given-names>EL</given-names></name><name><surname>McNew</surname><given-names>T</given-names></name><name><surname>Linker</surname><given-names>L</given-names></name><name><surname>Pfau</surname><given-names>J</given-names></name><name><surname>Black</surname><given-names>B</given-names></name><name><surname>Szeinuk</surname><given-names>J</given-names></name><name><surname>Flores</surname><given-names>R</given-names></name></person-group><article-title>Multiple pathway asbestos exposure assessment for a Superfund community</article-title><source>J Expo Sci Environ Epidemiol</source><year>2015</year><volume>25</volume><fpage>18</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">24756101</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>MR</given-names></name><name><surname>Crapo</surname><given-names>R</given-names></name><name><surname>Hankinson</surname><given-names>J</given-names></name><name><surname>Brusasco</surname><given-names>V</given-names></name><name><surname>Burgos</surname><given-names>F</given-names></name><name><surname>Casaburi</surname><given-names>R</given-names></name><name><surname>Coates</surname><given-names>A</given-names></name><name><surname>Enright</surname><given-names>P</given-names></name><name><surname>van der Grinten</surname><given-names>CP</given-names></name><name><surname>Gustafsson</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>DC</given-names></name><name><surname>MacIntyre</surname><given-names>N</given-names></name><name><surname>McKay</surname><given-names>R</given-names></name><name><surname>Navajas</surname><given-names>D</given-names></name><name><surname>Pedersen</surname><given-names>OF</given-names></name><name><surname>Pellegrino</surname><given-names>R</given-names></name><name><surname>Viegi</surname><given-names>G</given-names></name><name><surname>Wanger</surname><given-names>J</given-names></name></person-group><article-title>ATS/ERS Task Force. General considerations for lung function testing</article-title><source>Eur Respir J</source><year>2005</year><volume>26</volume><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">15994402</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hankinson</surname><given-names>JL</given-names></name><name><surname>Odencrantz</surname><given-names>JR</given-names></name><name><surname>Fedan</surname><given-names>KB</given-names></name></person-group><article-title>Spirometric reference values from a sample of the general U.S. population</article-title><source>Am J Respir Crit Care Med</source><year>1999</year><volume>159</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">9872837</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crapo</surname><given-names>RO</given-names></name><name><surname>Morris</surname><given-names>AH</given-names></name><name><surname>Gardner</surname><given-names>RM</given-names></name></person-group><article-title>Reference values for pulmonary tissue volume, membrane diffusing capacity, and pulmonary capillary blood volume</article-title><source>Bull Eur Physiopathol Respir</source><year>1982</year><volume>18</volume><fpage>893</fpage><lpage>899</lpage><pub-id pub-id-type="pmid">6927541</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Thornton</surname><given-names>JC</given-names></name><name><surname>Warshaw</surname><given-names>R</given-names></name><name><surname>Anderson</surname><given-names>H</given-names></name><name><surname>Teirstein</surname><given-names>AS</given-names></name><name><surname>Selikoff</surname><given-names>IJ</given-names></name></person-group><article-title>Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history</article-title><source>Am Rev Respir Dis</source><year>1983</year><volume>127</volume><fpage>270</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">6830050</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><collab>American Thoracic Society</collab><article-title>Diagnosis and initial management of nonmalignant diseases related to asbestos</article-title><source>Am J Respir Crit Care Med</source><year>2004</year><volume>170</volume><fpage>691</fpage><lpage>715</lpage><pub-id pub-id-type="pmid">15355871</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Kusaka</surname><given-names>Y</given-names></name><name><surname>Hering</surname><given-names>KG</given-names></name><name><surname>Parker</surname><given-names>JE</given-names></name></person-group><source>International classification of HRCT for occupational and environmental respiratory diseases</source><publisher-loc>Tokyo</publisher-loc><publisher-name>Springer-Verlag</publisher-name><year>2005</year></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="book"><collab>International Labour Organization</collab><source>Guidelines for the use of the ILO International Classification of Radiographs of Pneumoconioses. Revised edition 2011</source><publisher-loc>Geneva</publisher-loc><publisher-name>International Labour Office</publisher-name><comment><italic>Occupational Safety and Health Series</italic> No. 22 (Rev. 2011)</comment><year>2011</year></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elshazley</surname><given-names>M</given-names></name><name><surname>Shbiata</surname><given-names>E</given-names></name><name><surname>Hisanaga</surname><given-names>N</given-names></name><name><surname>Ichihara</surname><given-names>G</given-names></name><name><surname>Ewis</surname><given-names>AA</given-names></name><name><surname>Kamijima</surname><given-names>M</given-names></name><name><surname>Ichihara</surname><given-names>S</given-names></name><name><surname>Sakai</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Kondo</surname><given-names>M</given-names></name><name><surname>Hasegawa</surname><given-names>Y</given-names></name></person-group><article-title>Pleural plaque profiles on the chest radiographs and CT scans of asbestos-exposed Japanese construction workers</article-title><source>Ind Health</source><year>2011</year><volume>49</volume><fpage>626</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">21828957</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>DA</given-names></name><name><surname>Gamsu</surname><given-names>G</given-names></name><name><surname>Aberle</surname><given-names>DR</given-names></name></person-group><article-title>Conventional and high-resolution computed tomography in the diagnosis of asbestos-related diseases</article-title><source>Radiographics</source><year>1989</year><volume>9</volume><fpage>523</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">2727359</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>JG</given-names></name><name><surname>Webb</surname><given-names>WR</given-names></name><name><surname>Rosen</surname><given-names>A</given-names></name><name><surname>Gamsu</surname><given-names>G</given-names></name></person-group><article-title>Costal pleura: appearances at high-resolution CT</article-title><source>Radiol</source><year>1989</year><volume>171</volume><fpage>125</fpage><lpage>131</lpage></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>TC</given-names></name><name><surname>Antao</surname><given-names>VC</given-names></name><name><surname>Bove</surname><given-names>FJ</given-names></name><name><surname>Cusack</surname><given-names>C</given-names></name></person-group><article-title>Association between cumulative fiber exposure and respiratory outcomes among Libby vermiculite workers</article-title><source>J Occup Environ Med</source><year>2012</year><volume>54</volume><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">22227874</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>KA</given-names></name><name><surname>Flynn</surname><given-names>JJ</given-names></name><name><surname>Goodman</surname><given-names>JE</given-names></name><name><surname>Zu</surname><given-names>K</given-names></name><name><surname>Karmaus</surname><given-names>WJJ</given-names></name><name><surname>Mohr</surname><given-names>LC</given-names></name></person-group><article-title>Pleural plaques and their effect on lung function in Libby vermiculite miners</article-title><source>Chest</source><year>2014</year><volume>146</volume><fpage>786</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">24810738</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockey</surname><given-names>JE</given-names></name><name><surname>Dunning</surname><given-names>K</given-names></name><name><surname>Hilbert</surname><given-names>TJ</given-names></name><name><surname>Borton</surname><given-names>E</given-names></name><name><surname>Levin</surname><given-names>L</given-names></name><name><surname>Rice</surname><given-names>CH</given-names></name><name><surname>McKay</surname><given-names>RT</given-names></name><name><surname>Shipley</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Perme</surname><given-names>C</given-names></name><name><surname>LeMasters</surname><given-names>GK</given-names></name></person-group><article-title>HRCT/CT and associated spirometric effects in low Libby amphibole asbestos exposure</article-title><source>J Occup Environ Med</source><year>2015</year><volume>57</volume><fpage>6</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">25563535</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockey</surname><given-names>JE</given-names></name><name><surname>Dunning</surname><given-names>K</given-names></name><name><surname>Hilbert</surname><given-names>TJ</given-names></name><name><surname>Borton</surname><given-names>E</given-names></name><name><surname>Levin</surname><given-names>L</given-names></name><name><surname>Rice</surname><given-names>CH</given-names></name><name><surname>McKay</surname><given-names>RT</given-names></name><name><surname>Shipley</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Perme</surname><given-names>C</given-names></name><name><surname>LeMasters</surname><given-names>GK</given-names></name></person-group><article-title>Response to Comment on &#x0201c;HRCT/CT and associated spirometric effects of low Libby amphibole asbestos exposure&#x0201d;</article-title><source>J Occup Environ Med</source><year>2015</year><volume>57</volume><fpage>e80</fpage><lpage>e82</lpage></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clin</surname><given-names>B</given-names></name><name><surname>Paris</surname><given-names>C</given-names></name><name><surname>Ameille</surname><given-names>J</given-names></name><name><surname>Brochard</surname><given-names>P</given-names></name><name><surname>Conso</surname><given-names>F</given-names></name><name><surname>Gislard</surname><given-names>A</given-names></name><name><surname>Laurent</surname><given-names>F</given-names></name><name><surname>Letourneux</surname><given-names>M</given-names></name><name><surname>Luc</surname><given-names>A</given-names></name><name><surname>Schoerle</surname><given-names>E</given-names></name><name><surname>Pairon</surname><given-names>JC</given-names></name></person-group><article-title>Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis?</article-title><source>Thorax</source><year>2011</year><volume>66</volume><fpage>985</fpage><lpage>991</lpage><pub-id pub-id-type="pmid">21724747</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kee</surname><given-names>ST</given-names></name><name><surname>Gamsu</surname><given-names>G</given-names></name><name><surname>Blanc</surname><given-names>P</given-names></name></person-group><article-title>Causes of pulmonary impairment in asbestos-exposed individuals with diffuse pleural thickening</article-title><source>Am Rev Respir Dis</source><year>1996</year><volume>154</volume><fpage>789</fpage><lpage>793</lpage></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lillis</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Godbold</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>E</given-names></name><name><surname>Selikoff</surname><given-names>IJ</given-names></name></person-group><article-title>Pulmonary function and pleural fibrosis: quantitative relationships with an integrative index of pleural abnormalities</article-title><source>Am J Ind Med</source><year>1991</year><volume>20</volume><fpage>145</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">1951365</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Bhuptani</surname><given-names>A</given-names></name><name><surname>Sloane</surname><given-names>MF</given-names></name><name><surname>Brown</surname><given-names>LK</given-names></name><name><surname>Teirstein</surname><given-names>AS</given-names></name></person-group><article-title>Cardiorespiratory responses to incremental exercise in patients with asbestos-related pleural thickening and normal or slightly abnormal lung function</article-title><source>Chest</source><year>1993</year><volume>103</volume><fpage>1045</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">8131436</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockey</surname><given-names>JE</given-names></name><name><surname>Brooks</surname><given-names>SM</given-names></name><name><surname>Jarabek</surname><given-names>AM</given-names></name><name><surname>Khoury</surname><given-names>PR</given-names></name><name><surname>McKay</surname><given-names>RT</given-names></name><name><surname>Carson</surname><given-names>A</given-names></name><name><surname>Morrison</surname><given-names>JA</given-names></name><name><surname>Wiot</surname><given-names>JF</given-names></name><name><surname>Spitz</surname><given-names>HB</given-names></name></person-group><article-title>Pulmonary changes after exposure to vermiculite contaminated with fibrous tremolite</article-title><source>Am Rev Respir Dis</source><year>1984</year><volume>129</volume><fpage>952</fpage><lpage>958</lpage><pub-id pub-id-type="pmid">6329050</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>RS</given-names></name><name><surname>Abraham</surname><given-names>JL</given-names></name><name><surname>Haber</surname><given-names>P</given-names></name><name><surname>Burnett</surname><given-names>BR</given-names></name><name><surname>Morris</surname><given-names>P</given-names></name><name><surname>West</surname><given-names>P</given-names></name></person-group><article-title>Fatal asbestosis 50 years after brief high intensity exposure in a vermiculite expansion plant</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>165</volume><fpage>1145</fpage><lpage>1149</lpage><pub-id pub-id-type="pmid">11956059</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Ghimlas</surname><given-names>F</given-names></name><name><surname>Hoffstein</surname><given-names>V</given-names></name></person-group><article-title>Pleuroparenchymal lung disease secondary to nonoccupational exposure to vermiculite</article-title><source>Can Respir J</source><year>2007</year><volume>14</volume><fpage>164</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">17464381</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohs</surname><given-names>AM</given-names></name><name><surname>Lockey</surname><given-names>JE</given-names></name><name><surname>Dunning</surname><given-names>KK</given-names></name><name><surname>Shukla</surname><given-names>R</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Hilbert</surname><given-names>T</given-names></name><name><surname>Borton</surname><given-names>E</given-names></name><name><surname>Wiot</surname><given-names>J</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Shipley</surname><given-names>RT</given-names></name><name><surname>LeMasters</surname><given-names>GK</given-names></name><name><surname>Kapil</surname><given-names>V</given-names></name></person-group><article-title>Low-level fiber-induced radiologic changes caused by Libby vermiculite</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><volume>177</volume><fpage>630</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">18063841</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>BH</given-names></name><name><surname>Raleigh</surname><given-names>KK</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Mandel</surname><given-names>JH</given-names></name><name><surname>Adgate</surname><given-names>JL</given-names></name><name><surname>Ramachandran</surname><given-names>G</given-names></name><name><surname>Messing</surname><given-names>RB</given-names></name><name><surname>Eshenaur</surname><given-names>T</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name></person-group><article-title>Radiologic evidence of nonoccupational asbestos exposure from processing Libby vermiculite in Minneapolis, Minnesota</article-title><source>Environ Health Perspect</source><year>2012</year><volume>120</volume><fpage>44</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">21992801</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilbert</surname><given-names>TJ</given-names></name><name><surname>Franzblau</surname><given-names>A</given-names></name><name><surname>Dunning</surname><given-names>KK</given-names></name><name><surname>Borton</surname><given-names>EK</given-names></name><name><surname>Rohs</surname><given-names>AM</given-names></name><name><surname>Lockey</surname><given-names>JE</given-names></name></person-group><article-title>Asbestos-related radiologic findings among household contacts of workers exposed to Libby vermiculite</article-title><source>J Occup Environ Med</source><year>2013</year><volume>55</volume><fpage>1300</fpage><lpage>1304</lpage><pub-id pub-id-type="pmid">24164758</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>KY</given-names></name><name><surname>Bateson</surname><given-names>TF</given-names></name><name><surname>Kopylev</surname><given-names>L</given-names></name></person-group><article-title>Low levels of exposure to Libby amphibole asbestos and localized pleural thickening</article-title><source>J Occup Environ Med</source><year>2013</year><volume>55</volume><fpage>1350</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">24164765</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Libby Vermiculite Miners cohort</title></caption><graphic xlink:href="nihms907538f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Lamellar Pleural Thickening</title><p id="P60">Figure 2<italic>A</italic> illustrates side-by-side chest CT images in extended lung windows and mediastinal windows of a miner with lamellar PT who is included in the present series. Lung window shows the characteristic thin layer of pleural thickening extending internal and parallel to the ribs, that has been characterized by the authors as lamellar thickening (arrows). This thickening can best be seen on the lung windows due to technical factors that make it less visible on mediastinal windows (Figure 2<italic>B</italic>, arrows). Figures 2<italic>C1</italic> and <italic>2C2</italic> show two surgical images of the parietal pleura of this same patient during a thoracotomy for a lung cancer (Figure 2<italic>D</italic>, arrow). A thin layer of parietal pleural thickening that corresponds to the chest CT scan image of lamellar PT is clearly visible (black arrows), the remainder of the pleura is opaque.</p><p id="P61">AO = aorta; CW = parietal chest wall; H = heart; LUL = left upper lobe; LLL = left lower lobe; LLA = left lower lobe artery; LLB = left lower lobe bronchus; LLV = left lower lobe vein; PT = pleural thickening.</p><p id="P62">(Surgical photos courtesy of Dr. Steven J. Nisco, MD, Thoracic Surgeon, Providence Spokane Heart Institute, Spokane, WA)</p></caption><graphic xlink:href="nihms907538f2a"/><graphic xlink:href="nihms907538f2b"/><graphic xlink:href="nihms907538f2c"/><graphic xlink:href="nihms907538f2d"/><graphic xlink:href="nihms907538f2e"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p id="P63">Demographic characteristics, smoking history and exposure history of miners</p></caption><table frame="box" rules="all"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">N (%)</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1"><italic>Gender</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">13 (5.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">243 (94.9)</td></tr><tr><td align="left" colspan="2" rowspan="1"><italic>Age group</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">30 &#x02013; 54 years</td><td align="left" rowspan="1" colspan="1">37 (14.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">55 &#x02013; 64 years</td><td align="left" rowspan="1" colspan="1">104 (40.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">65 + years</td><td align="left" rowspan="1" colspan="1">115 (44.9)</td></tr><tr><td align="left" colspan="2" rowspan="1"><italic>Body Mass Index Category (BMI data missing for 33)</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Normal (&#x0003c; 25 kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">26 (11.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Overweight (25&#x02013;29.9 kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">80 (35.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Obese (&#x0003e;= 30 kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">117 (52.5)</td></tr><tr><td align="left" colspan="2" rowspan="1"><italic>Smoking History</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Never</td><td align="left" rowspan="1" colspan="1">89 (34.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Current</td><td align="left" rowspan="1" colspan="1">43 (16.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Former</td><td align="left" rowspan="1" colspan="1">123 (48.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Missing/Refused</td><td align="left" rowspan="1" colspan="1">1 (0.4)</td></tr><tr><td align="left" colspan="2" rowspan="1"><italic>Latency (years since first worked at or contracted for WR Grace)</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">21&#x02013;33</td><td align="left" rowspan="1" colspan="1">65 (25.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">34&#x02013;38</td><td align="left" rowspan="1" colspan="1">65 (25.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">39&#x02013;43</td><td align="left" rowspan="1" colspan="1">60 (23.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">44&#x02013;69</td><td align="left" rowspan="1" colspan="1">66 (25.8)</td></tr><tr><td align="left" colspan="2" rowspan="1"><italic>Years lived in Lincoln County prior to 1990</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003c; 7 years</td><td align="left" rowspan="1" colspan="1">61 (23.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">7 &#x02013; 16 years</td><td align="left" rowspan="1" colspan="1">66 (25.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">17 &#x02013; 24 years</td><td align="left" rowspan="1" colspan="1">60 (23.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">25 + years</td><td align="left" rowspan="1" colspan="1">69 (27.0)</td></tr><tr><td align="left" colspan="2" rowspan="1"><italic>Years worked at WRG</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">0.6 to 1.5 years</td><td align="left" rowspan="1" colspan="1">87 (34.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">1.6 to 5 years</td><td align="left" rowspan="1" colspan="1">84 (32.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">5.1 to 40 years</td><td align="left" rowspan="1" colspan="1">85 (33.2)</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p id="P64">CT findings (Mutually exclusive)</p></caption><table frame="box" rules="all"><thead><tr><th align="left" rowspan="1" colspan="1">CT Findings</th><th align="left" rowspan="1" colspan="1">Number</th><th align="left" rowspan="1" colspan="1">Percent</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>Normal</italic></td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">11.7</td></tr><tr><td align="left" colspan="3" rowspan="1"><italic>Pleural Thickening with no other findings</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;CPT only</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">13.7</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Both types, but predominantly CPT</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">4.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;LPT only</td><td align="left" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">20.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Both types but predominantly LPT</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">14.5</td></tr><tr><td align="left" colspan="3" rowspan="1"><italic>Pleural Thickening + irregular opacities</italic><xref ref-type="table-fn" rid="TFN1">a</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;CPT<xref ref-type="table-fn" rid="TFN2">b</xref> + irregular opacities</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">2.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;LPT<xref ref-type="table-fn" rid="TFN3">c</xref> + irregular opacities</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">10.6</td></tr><tr><td align="left" colspan="3" rowspan="1"><italic>Pleural Thickening + emphysema</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;CPT<xref ref-type="table-fn" rid="TFN2">b</xref> + emphysema</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">6.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;LPT<xref ref-type="table-fn" rid="TFN3">c</xref> + emphysema</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">9.8</td></tr><tr><td align="left" colspan="3" rowspan="1"><italic>Pleural Thickening + irregular opacities + emphysema</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;CPT<xref ref-type="table-fn" rid="TFN2">b</xref> + irregular opacities + emphysema</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">2.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;LPT<xref ref-type="table-fn" rid="TFN3">c</xref> + irregular opacities + emphysema</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">3.9</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Irregular opacities only</italic></td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Emphysema only</italic></td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Total</bold></td><td align="left" rowspan="1" colspan="1"><bold>256</bold></td><td align="left" rowspan="1" colspan="1"><bold>100</bold></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p id="P65">Irregular opacities include intra (including subpleural curvilinear opacities, 3 cases), interlobular opacities (45 cases) and honeycombing (1 case). Location of these abnormalities was predominantly in the middle and lower lobes in all cases.</p></fn><fn id="TFN2"><label>b</label><p id="P66">Includes those with CPT and those with both types, but predominantly CPT.</p></fn><fn id="TFN3"><label>c</label><p id="P67">Includes those with LPT and those with both types, but predominantly LPT.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="landscape"><label>Table 3</label><caption><p id="P68">Demographic characteristics, smoking history and exposure history of miners according to CT findings.</p></caption><table frame="box" rules="all"><thead><tr><th align="left" rowspan="2" valign="top" colspan="1"/><th align="center" rowspan="2" valign="top" colspan="1">Normal<xref ref-type="table-fn" rid="TFN5">b</xref></th><th align="center" colspan="4" valign="top" rowspan="1">Pleural thickening with no other findings</th><th align="center" colspan="2" valign="top" rowspan="1">Pleural thickening + irregular<break/>opacities<xref ref-type="table-fn" rid="TFN4">a</xref></th><th align="center" rowspan="2" valign="top" colspan="1">Emphysema<break/>+ (Pleural<break/>thickening<break/>and/or<break/>irregular<break/>opacities)<xref ref-type="table-fn" rid="TFN6">c</xref></th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">CPT<break/>only</th><th align="center" valign="top" rowspan="1" colspan="1">Both types,<break/>predominantly<break/>CPT</th><th align="center" valign="top" rowspan="1" colspan="1">LPT<break/>only</th><th align="center" valign="top" rowspan="1" colspan="1">Both types,<break/>predominantly<break/>LPT</th><th align="center" valign="top" rowspan="1" colspan="1">CPT<xref ref-type="table-fn" rid="TFN8">e</xref> +<break/>irregular<break/>opacities</th><th align="center" valign="top" rowspan="1" colspan="1">LPT<xref ref-type="table-fn" rid="TFN9">f</xref> + irregular<break/>opacities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total, n</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">Age, years</td><td align="center" rowspan="1" colspan="1">62 (8.2)</td><td align="center" rowspan="1" colspan="1">63 (8.2)</td><td align="center" rowspan="1" colspan="1">66 (6.2)</td><td align="center" rowspan="1" colspan="1">59 (8.9)</td><td align="center" rowspan="1" colspan="1">63 (8.6)</td><td align="center" rowspan="1" colspan="1">72 (7.3)<xref ref-type="table-fn" rid="TFN10">*</xref></td><td align="center" rowspan="1" colspan="1">72 (8.7)<xref ref-type="table-fn" rid="TFN11">**</xref></td><td align="center" rowspan="1" colspan="1">68 (7.0)<xref ref-type="table-fn" rid="TFN11">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Gender, % male</td><td align="center" rowspan="1" colspan="1">76.7%</td><td align="center" rowspan="1" colspan="1">97.1%<xref ref-type="table-fn" rid="TFN10">*</xref></td><td align="center" rowspan="1" colspan="1">90.9%</td><td align="center" rowspan="1" colspan="1">100%<xref ref-type="table-fn" rid="TFN11">**</xref></td><td align="center" rowspan="1" colspan="1">97.3%<xref ref-type="table-fn" rid="TFN10">*</xref></td><td align="center" rowspan="1" colspan="1">100%</td><td align="center" rowspan="1" colspan="1">100%<xref ref-type="table-fn" rid="TFN10">*</xref></td><td align="center" rowspan="1" colspan="1">94.7%<xref ref-type="table-fn" rid="TFN10">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (BMI, kg/m<sup>2</sup>)<xref ref-type="table-fn" rid="TFN7">d</xref></td><td align="center" rowspan="1" colspan="1">31 (7.2)</td><td align="center" rowspan="1" colspan="1">32 (9.0)</td><td align="center" rowspan="1" colspan="1">33 (4.9)</td><td align="center" rowspan="1" colspan="1">32 (7.2)</td><td align="center" rowspan="1" colspan="1">32 (4.8)</td><td align="center" rowspan="1" colspan="1">27 (1.8)</td><td align="center" rowspan="1" colspan="1">31 (6.7)</td><td align="center" rowspan="1" colspan="1">28 (6.1)<xref ref-type="table-fn" rid="TFN10">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking history, % current or former</td><td align="center" rowspan="1" colspan="1">56.7%</td><td align="center" rowspan="1" colspan="1">54.3%</td><td align="center" rowspan="1" colspan="1">54.6%</td><td align="center" rowspan="1" colspan="1">51.9%</td><td align="center" rowspan="1" colspan="1">73.0%</td><td align="center" rowspan="1" colspan="1">20.0%</td><td align="center" rowspan="1" colspan="1">63.0%</td><td align="center" rowspan="1" colspan="1">91.1<xref ref-type="table-fn" rid="TFN11">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Latency (years since first worked at WRG)</td><td align="center" rowspan="1" colspan="1">35 (6.1)</td><td align="center" rowspan="1" colspan="1">39 (8.1)<xref ref-type="table-fn" rid="TFN10">*</xref></td><td align="center" rowspan="1" colspan="1">43 (6.6)<xref ref-type="table-fn" rid="TFN11">**</xref></td><td align="center" rowspan="1" colspan="1">36 (7.3)</td><td align="center" rowspan="1" colspan="1">40 (8.2)<xref ref-type="table-fn" rid="TFN10">*</xref></td><td align="center" rowspan="1" colspan="1">41 (6.1)</td><td align="center" rowspan="1" colspan="1">44 (11)<xref ref-type="table-fn" rid="TFN11">**</xref></td><td align="center" rowspan="1" colspan="1">40 (7.4)<xref ref-type="table-fn" rid="TFN11">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Years worked at WRG</td><td align="center" rowspan="1" colspan="1">5.1 (5.9)</td><td align="center" rowspan="1" colspan="1">4.1 (6.1)</td><td align="center" rowspan="1" colspan="1">5.8 (6.4)</td><td align="center" rowspan="1" colspan="1">7.6 (8.9)</td><td align="center" rowspan="1" colspan="1">6.7 (6.8)</td><td align="center" rowspan="1" colspan="1">4.6 (3.8)</td><td align="center" rowspan="1" colspan="1">8.8 (8.8)</td><td align="center" rowspan="1" colspan="1">6.6 (7.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Years of residence</td><td align="center" rowspan="1" colspan="1">13 (9.4)</td><td align="center" rowspan="1" colspan="1">18 (12)</td><td align="center" rowspan="1" colspan="1">20 (10)</td><td align="center" rowspan="1" colspan="1">18 (13)</td><td align="center" rowspan="1" colspan="1">19 (13)</td><td align="center" rowspan="1" colspan="1">13 (11)</td><td align="center" rowspan="1" colspan="1">18 (17)</td><td align="center" rowspan="1" colspan="1">19 (13)<xref ref-type="table-fn" rid="TFN10">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Total environment exposure, weighted years</td><td align="center" rowspan="1" colspan="1">2.7 (4.5)</td><td align="center" rowspan="1" colspan="1">3.1 (5.6)</td><td align="center" rowspan="1" colspan="1">2.2 (2.4)</td><td align="center" rowspan="1" colspan="1">3.6 (4.4)</td><td align="center" rowspan="1" colspan="1">2.7 (3.6)</td><td align="center" rowspan="1" colspan="1">1.8 (2.2)</td><td align="center" rowspan="1" colspan="1">2.8 (2.9)</td><td align="center" rowspan="1" colspan="1">2.0 (2.8)</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>a</label><p id="P69">Table excludes those with irregular opacity findings only (n=2).</p></fn><fn id="TFN5"><label>b</label><p id="P70">No pleural or parenchymal findings.</p></fn><fn id="TFN6"><label>c</label><p id="P71">Includes one observation with emphysema findings only.</p></fn><fn id="TFN7"><label>d</label><p id="P72">Missing BMI data for 33.</p></fn><fn id="TFN8"><label>e</label><p id="P73">Includes those with CPT and those with both types, but predominantly CPT.</p></fn><fn id="TFN9"><label>f</label><p id="P74">Includes those with LPT and those with both types, but predominantly LPT.</p></fn><fn id="TFN10"><label>*</label><p id="P75">p &#x0003c; 0.05;</p></fn><fn id="TFN11"><label>**</label><p id="P76">p &#x0003c; 0.01 comparing to Normal group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float" orientation="landscape"><label>Table 4</label><caption><p id="P77">Mean (SD) percent predicted<xref ref-type="table-fn" rid="TFN13">a</xref> pulmonary function measures with respect to CT findings</p></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">CT grouping<xref ref-type="table-fn" rid="TFN14">b</xref></th><th align="center" rowspan="1" colspan="1">FEV<sub>1</sub><break/>(n = 226)</th><th align="center" rowspan="1" colspan="1">FVC<break/>(n = 226)</th><th align="center" rowspan="1" colspan="1">FEV<sub>1</sub>/FVC<break/>(n = 226)</th><th align="center" rowspan="1" colspan="1">TLC<break/>(n = 134)</th><th align="center" rowspan="1" colspan="1">RV<break/>(n = 134)</th><th align="center" rowspan="1" colspan="1">DLco<break/>(n = 157)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>Normal</italic><xref ref-type="table-fn" rid="TFN15">c</xref></td><td align="center" rowspan="1" colspan="1">95.7 (14.1)</td><td align="center" rowspan="1" colspan="1">93.6 (13.5)</td><td align="center" rowspan="1" colspan="1">0.78 (0.07)</td><td align="center" rowspan="1" colspan="1">97.2 (14.5)</td><td align="center" rowspan="1" colspan="1">110 (34.5)</td><td align="center" rowspan="1" colspan="1">95.7 (15.5)</td></tr><tr><td align="left" colspan="7" rowspan="1"><italic>Pleural thickening</italic><xref ref-type="table-fn" rid="TFN16">d</xref>
<italic>with no other findings</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;CPT</td><td align="center" rowspan="1" colspan="1">89.4 (18.2)</td><td align="center" rowspan="1" colspan="1">90.1 (17.6)</td><td align="center" rowspan="1" colspan="1">0.75 (0.08)</td><td align="center" rowspan="1" colspan="1">93.8 (17.9)</td><td align="center" rowspan="1" colspan="1">105 (30.4)</td><td align="center" rowspan="1" colspan="1">102 (21.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;LPT</td><td align="center" rowspan="1" colspan="1">87.3 (15.9)</td><td align="center" rowspan="1" colspan="1">89.0 (15.0)</td><td align="center" rowspan="1" colspan="1">0.75 (0.08)</td><td align="center" rowspan="1" colspan="1">94.1 (14.2)</td><td align="center" rowspan="1" colspan="1">112 (24.9)</td><td align="center" rowspan="1" colspan="1">91.5 (20.1)</td></tr><tr><td align="left" colspan="7" rowspan="1"><italic>Pleural thickening</italic><xref ref-type="table-fn" rid="TFN16">d</xref>
<italic>with irregular opacities</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;CPT + irregular opacities</td><td align="center" rowspan="1" colspan="1">82.2 (22.2)</td><td align="center" rowspan="1" colspan="1">84.0 (20.8)</td><td align="center" rowspan="1" colspan="1">0.73 (0.09)</td><td align="center" rowspan="1" colspan="1">95.5 (9.8)</td><td align="center" rowspan="1" colspan="1">113 (7.1)</td><td align="center" rowspan="1" colspan="1">110 (10.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;LPT + irregular opacities</td><td align="center" rowspan="1" colspan="1">71.7 (19.9)<xref ref-type="table-fn" rid="TFN17">*</xref></td><td align="center" rowspan="1" colspan="1">73.3 (17.5)<xref ref-type="table-fn" rid="TFN17">*</xref></td><td align="center" rowspan="1" colspan="1">0.72 (0.10)<xref ref-type="table-fn" rid="TFN17">*</xref></td><td align="center" rowspan="1" colspan="1">73.9 (13.1)<xref ref-type="table-fn" rid="TFN17">*</xref></td><td align="center" rowspan="1" colspan="1">83.0 (19.2)<xref ref-type="table-fn" rid="TFN17">*</xref></td><td align="center" rowspan="1" colspan="1">67.3 (19.2)<xref ref-type="table-fn" rid="TFN17">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Emphysema + (pleural thickening and/or irregular opacities)</italic></td><td align="center" rowspan="1" colspan="1">74.7 (20.7)<xref ref-type="table-fn" rid="TFN17">*</xref></td><td align="center" rowspan="1" colspan="1">83.9 (16.0)<xref ref-type="table-fn" rid="TFN17">*</xref></td><td align="center" rowspan="1" colspan="1">0.66 (0.12)<xref ref-type="table-fn" rid="TFN17">*</xref></td><td align="center" rowspan="1" colspan="1">92.7 (17.8)</td><td align="center" rowspan="1" colspan="1">113 (29.9)</td><td align="center" rowspan="1" colspan="1">71.1 (18.9)<xref ref-type="table-fn" rid="TFN17">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN12"><p id="P78">FEV<sub>1</sub> First second forced expiratory volume; FVC: Forced vital capacity; TLC = Total lung capacity; RV = Residual volume; DLco: Carbon monoxide diffusing capacity; CPT = circumscribed pleural thickening; LPT = lamellar pleural thickening</p></fn><fn id="TFN13"><label>a</label><p id="P79">Ratio for FEV<sub>1</sub>/FVC.</p></fn><fn id="TFN14"><label>b</label><p id="P80">Excludes one CT with irregular opacities only and one CT with emphysema only.</p></fn><fn id="TFN15"><label>c</label><p id="P81">No pleural or parenchymal findings.</p></fn><fn id="TFN16"><label>d</label><p id="P82">CT findings with both pleural thickening were classified according to the predominant finding as identified by the radiologists.</p></fn><fn id="TFN17"><label>*</label><p id="P83">Least squares means different from Normal group (p &#x0003c; 0.05), adjusted for latency and smoking history.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="float" orientation="landscape"><label>Table 5</label><caption><p id="P84">Odds ratios (and 95% confidence interval (CI)) for abnormal<xref ref-type="table-fn" rid="TFN19">a</xref> pulmonary function measures with respect to CT findings</p></caption><table frame="box" rules="all"><thead><tr><th align="left" rowspan="2" valign="top" colspan="1">CT<break/>findings<xref ref-type="table-fn" rid="TFN20">b</xref></th><th align="center" colspan="3" valign="top" rowspan="1">FEV<sub>1</sub></th><th align="center" colspan="3" valign="top" rowspan="1">FVC</th><th align="center" colspan="3" valign="top" rowspan="1">DLco</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">No.<break/>abnormal<break/>(%)</th><th align="center" valign="top" rowspan="1" colspan="1">Model 1<xref ref-type="table-fn" rid="TFN21">c</xref><break/>OR<break/>(95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1">Model 2<xref ref-type="table-fn" rid="TFN22">d</xref><break/>OR<break/>(95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1">No.<break/>abnormal<break/>(%)</th><th align="center" rowspan="1" colspan="1">Model 1<xref ref-type="table-fn" rid="TFN21">c</xref><break/>OR<break/>(95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1">Model 2<xref ref-type="table-fn" rid="TFN22">d</xref><break/>OR<break/>(95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1">No.<break/>abnormal<break/>(%)</th><th align="center" valign="top" rowspan="1" colspan="1">Model 1<xref ref-type="table-fn" rid="TFN21">c</xref><break/>OR<break/>(95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1">Model 2<xref ref-type="table-fn" rid="TFN22">d</xref><break/>OR<break/>(95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="10" rowspan="1"><italic>Pleural thickening</italic><xref ref-type="table-fn" rid="TFN23">e</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;No</td><td align="center" rowspan="1" colspan="1">4 (14)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">3 (10)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">2 (13)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;CPT</td><td align="center" rowspan="1" colspan="1">18 (29)</td><td align="center" rowspan="1" colspan="1">0.7 (0.3 &#x02013; 1.3)</td><td align="center" rowspan="1" colspan="1">1.7 (0.5 &#x02013; 5.9)</td><td align="center" rowspan="1" colspan="1">17 (27)</td><td align="center" rowspan="1" colspan="1">0.7 (0.4 &#x02013; 1.4)</td><td align="center" rowspan="1" colspan="1">2.6 (0.7&#x02013;10)</td><td align="center" rowspan="1" colspan="1">8 (21)</td><td align="center" rowspan="1" colspan="1">0.7 (0.3 &#x02013; 1.8)</td><td align="center" rowspan="1" colspan="1">0.9 (0.1 &#x02013; 6.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;LPT</td><td align="center" rowspan="1" colspan="1">57 (42)</td><td align="center" rowspan="1" colspan="1">2.2 (1.2 &#x02013; 4.1)</td><td align="center" rowspan="1" colspan="1">2.7 (0.9&#x02013;8.7)</td><td align="center" rowspan="1" colspan="1">83 (61)</td><td align="center" rowspan="1" colspan="1">2.1 (1.2 &#x02013; 3.9)</td><td align="center" rowspan="1" colspan="1">3.9 (1.1 &#x02013; 14)</td><td align="center" rowspan="1" colspan="1">30 (29)</td><td align="center" rowspan="1" colspan="1">1.6 (0.7 &#x02013; 3.9)</td><td align="center" rowspan="1" colspan="1">1.3 (0.2 &#x02013; 7.2)</td></tr><tr><td align="left" colspan="10" rowspan="1"><italic>Irregular opacities</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;No</td><td align="center" rowspan="1" colspan="1">54(29)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">51 (27)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">23 (18)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Yes</td><td align="center" rowspan="1" colspan="1">21 (61)</td><td align="center" rowspan="1" colspan="1">5.0 (2.2 &#x02013; 11)</td><td align="center" rowspan="1" colspan="1">4.2 (1.8 &#x02013; 9.5)</td><td align="center" rowspan="1" colspan="1">22 (54)</td><td align="center" rowspan="1" colspan="1">2.9 (1.4 &#x02013; 6.0)</td><td align="center" rowspan="1" colspan="1">2.5 (1.2 &#x02013; 5.3)</td><td align="center" rowspan="1" colspan="1">17 (61)</td><td align="center" rowspan="1" colspan="1">6.9 (2.6 &#x02013; 18)</td><td align="center" rowspan="1" colspan="1">6.6 (2.4 &#x02013; 18)</td></tr><tr><td align="left" colspan="10" rowspan="1"><italic>Emphysema</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;No</td><td align="center" rowspan="1" colspan="1">50 (28)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">55 (31)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">25 (20)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Yes</td><td align="center" rowspan="1" colspan="1">19 (40)</td><td align="center" rowspan="1" colspan="1">3.0 (1.5 &#x02013; 6.0)</td><td align="center" rowspan="1" colspan="1">2.7 (1.3 &#x02013; 5.8)</td><td align="center" rowspan="1" colspan="1">18 (38)</td><td align="center" rowspan="1" colspan="1">1.3 (0.6 &#x02013; 2.6)</td><td align="center" rowspan="1" colspan="1">1.1 (0.5 &#x02013; 2.3)</td><td align="center" rowspan="1" colspan="1">15 (48)</td><td align="center" rowspan="1" colspan="1">3.0 (1.3 &#x02013; 7.3)</td><td align="center" rowspan="1" colspan="1">3.0 (1.2 &#x02013; 7.7)</td></tr></tbody></table><table-wrap-foot><fn id="TFN18"><p id="P85">FEV<sub>1</sub> First second forced expiratory volume; FVC: Forced vital capacity; DLco: Carbon monoxide diffusing capacity; CPT = circumscribed pleural thickening; LPT = lamellar pleural thickening</p></fn><fn id="TFN19"><label>a</label><p id="P86">Below lower limit of normal (LLN).</p></fn><fn id="TFN20"><label>b</label><p id="P87">Presence/absence of a given CT finding irrespective of concurrent CT findings.</p></fn><fn id="TFN21"><label>c</label><p id="P88">Model 1: Adjusted for latency (years since first worked at the mine) and smoking history (current/former versus never).</p></fn><fn id="TFN22"><label>d</label><p id="P89">Model 2: Adjusted for latency, smoking history and concurrent CT findings.</p></fn><fn id="TFN23"><label>e</label><p id="P90">CT findings with both pleural thickening types were classified according to the predominant finding as identified by the radiologists.</p></fn></table-wrap-foot></table-wrap></floats-group></article>